MariMed Inc.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $41.9M | $39.5M | $41.7M | $40.8M | $39.5M | $37.9M | $38.7M | $40.6M |
| Cost of Revenue | $25.7M | $24.2M | $31.1M | $24.4M | $23.6M | $22.8M | $26.3M | $23.8M |
| Gross Profit | $16.2M | $15.3M | $10.5M | $16.4M | $15.9M | $15.1M | $12.5M | $16.8M |
| Gross Margin | 38.7% | 38.7% | 25.2% | 40.1% | 40.3% | 39.8% | 32.1% | 41.3% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $6.9M | $6.9M | $7.0M | $6.6M | $6.3M | $6.3M | $6.6M | $6.1M |
| Operating Income | $418.0K | $125.0K | $-4.5M | $1.6M | $1.0M | $-910.0K | $-1.7M | $1.3M |
| Operating Margin | 1.0% | 0.3% | -10.9% | 3.9% | 2.6% | -2.4% | -4.4% | 3.3% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $-1.6M | $-1.1M | $-7.3M | $-182.0K | $-704.0K | $-2.6M | $-3.6M | $-335.0K |
| Income Tax Expense | $2.0M | $2.7M | $-2.7M | $2.8M | $691.0K | $2.8M | $4.9M | $655.0K |
| Net Income | $-3.6M | $-3.8M | $-4.6M | $-2.9M | $-1.4M | $-5.5M | $-8.5M | $-1.0M |
| Net Margin | -8.6% | -9.6% | -11.1% | -7.2% | -3.5% | -14.5% | -22.0% | -2.5% |
| EPS (Basic) | $-0.01 | $-0.01 | $-0.02 | $-0.01 | $0.00 | $-0.01 | $-0.03 | $0.00 |
| EPS (Diluted) | $-0.01 | $-0.01 | $-0.02 | $-0.01 | $0.00 | $-0.01 | $-0.03 | $0.00 |
| Shares Outstanding (Basic) | 399.6M | 397.5M | 390.1M | 392.6M | 389.9M | 382.6M | 379.2M | 380.6M |
| Shares Outstanding (Diluted) | 399.6M | 397.5M | 390.1M | 392.6M | 389.9M | 382.6M | 379.2M | 380.6M |
| Dividends Per Share | — | — | — | — | — | — | — | — |